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ABSTRACT Reverse transcriptase of murine retroviruses
is a monomeric protein of -80,000 daltons, which is encoded
by the central portion of the viral pol gene. To prepare large
quantities of the enzyme, we have constructed gene fusions
between the trpE gene and portions of the poi gene of Moloney
murine leukemia virus. The insertedpol gene sequences include
the entire coding region for the mature enzyme and various
amounts of additional coding sequences. Many of these con-
structs express high levels of reverse transcriptase activity even
though the NH2 and COOH termini of the protein product only
approximate the correct termini of the authentic protein.
The synthesis of retroviral DNA is catalyzed by the enzyme
reverse transcriptase, encoded by the viral pol gene. The
enzyme can efficiently utilize either RNA or DNA templates
for DNA synthesis by the elongation of a primer bearing a
paired 3' hydroxyl terminus (1-6). The po gene is initially
expressed in the form of a large polyprotein precursor,
containing sequences encoded by the gag gene fused to
sequences encoded by the po gene; proteolytic processing is
required to remove the gag sequences and to excise the
mature products from the po sequences (7). In the murine
retroviruses, the po sequences are processed to three
nonoverlapping products: a small protein encoded by the 5'
end of the gene, the protease needed for gag and poc
processing (8); reverse transcriptase, the largest protein,
encoded by the middle of the gene; and a protein encoded by
the 3' end, apparently involved in integration of the provirus
(9, 10). To facilitate characterization of these proteins, we
have generated constructs that express portions of the pol
gene of the Moloney murine leukemia virus in Escherichia
coli. Several of these constructs were found to express active
reverse transcriptase.
MATERIALS AND METHODS
Bacteria and Plasmids. E. coli strain HB101 (recA13-,
hsdR-, hsdM-, lac YJ, SupE44) was used as the host for most
experiments (11). Strain C2110 (his-, rha-, polAl-) was the
gift of D. Figurski. The trpE fusion vector pATH1, was the
generous gift ofT. J. Koerner and A. Tzagoloff. The po gene
was derived from plasmid pT11 (12).
Enzymatic Reactions. DNA fragments were purified by
agarose gel electrophoresis and recovered with glass powder
(13). DNA was treated with exonuclease BAL 31, nuclease
S1, and T4 DNA ligase as described (14). Reverse
transcriptase assays measured the incorporation of radioac-
tive dTTP into homopolymer on synthetic templates (15).
DNA Sequencing. The bases in pSHNI36 flanking the site of
deletion were determined by the procedure of Maxam and
Gilbert (16). Plasmid DNA was 5'-end-labeled at HincII sites
with polynucleotide kinase and cleaved again with Rsa I to
prepare a 240-base-pair (bp) fragment labeled at one end.
Preparation of Crude Lysates. These procedures were
modifications of the method of Kleid et al. (17). Cultures (0.5
ml) were grown to stationary phase in M9 medium (18) with
0.5% Casamino acids/thiamine (10 ,ug/ml)/tryptophan (20
,ug/ml)/ampicillin (50 gg/ml), diluted 1:10 into medium
without tryptophan, and grown for 1 hr at 300C. The cells
were induced by addition of indoleacrylic acid to 5 gg/ml,
grown an additional 2 hr, and harvested by centrifugation.
Preparation of total protein extracts for enzymatic assays,
and the subsequent separation of proteins into soluble and
insoluble fractions were carried out as described (17). Ex-
tracts made by the dilute lysis procedure were prepared from
small cultures lysed in 1/10th vol, and extracts made by the
concentrated lysis procedure were made from 500-ml cul-
tures lysed in 1/200th vol.
Immunopretipitations. Cells were labeled by addition of
[35S]methionine to 40 ,kCi/ml (1 Ci = 37 GBq) at the time of
induction, treated with lysozyme as described above, and
lysed with buffer A (1% Triton X-100/0.5% sodium
deoxycholate/0.1% NaDodSO4/10 mM sodium phosphate,
pH 7.5/0.1 M NaCl) for 15 min at 0C. After addition of fixed
Staphylococcus aureus cells (Pansorbin, CalBiochem), the
lysate was clarified (45,000 rpm; 90 min), and incubated with
antiserum overnight. The immune complexes were adsorbed
to fixed S. aureus cells for 1 hr at 0C, collected, and analyzed
by NaDodSO4/polyacrylamide gel electrophoresis as de-
scribed (14).
Partial Purification of pSHl and pSHNB6 Proteins. HB101
cells bearing pSH1 or pSHNB6 were grown to stationary
phase at 370C and induced as described above,; The cells were
collected by centrifugation, washed, resuspended in 1/200th
vol of buffer (50 mM Tris HCl, pH 7.5/0.5 mM EDTA/0.3 M
NaCl), and treated with lysozyme (1 mg/ml) at0C for 30 min.
The cells were lysed with Nonidet P-40 (NP40) (0.2%), and
the lysate was made 1 M in NaCl, clarified at 8000 x g for 30
min, and dialyzed against buffer B [50mM Tris HCl, pH 8.0/1
mM EDTA/1 mM dithiothreitol/10% (vol/vol) glycerol]
containing 0.1% NP40 and 25 mM NaCl. DNA was precip-
itated by the addition of 0.3 vol of streptomycin sulfate
solution (5% in buffer B containing 25 mM NaCl), and the
supernatant was applied to a DEAE-cellulose column (DE52;
Whatman) equilibrated with buffer B containing 25 mM
NaCl. The activity was eluted with buffer B containing 0.2 M
NaCl.
Ammonium Sulfate Fractionations. Activity eluted from
DEAE cellulose columns was precipitated by the addition of
solid ammonium sulfate to the appropriate concentration.
The solution was stirred for 1 hr, and the precipitate was
pelleted (11,000 rpm; 30 min).
Abbreviations: bp, base pair(s); MalNEt, N-ethylmaleimide.
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RESULTS
Construction of trpE-pol Gene Fusion. In our initial effort to
express reverse transcriptase, we chose a fragment from the
central portion of the pol gene of a cloned biologically active
copy ofthe Moloney murine leukemia virus genome (12). Sac
I cleaves within the 5' portion of the pol gene encoding the
viral protease; a deletion mutation near this site does not
affect reverse transcriptase activity (8). HindIII makes a
single cleavage in the 3' portion of the poi gene, and deletions
at this site also do not affect production of the enzyme (9).
The 2.5-kilobase fragment produced by cleavage with Sac I
and HindIII was isolated and inserted into the polylinker
sequence ofthe expression vector pATH1 (T. J. Koerner and
A. Tzagoloff, personal communication). The resulting plas-
mid, pSH1, contained the trp promoter, a portion of the trpE
gene, and the coding region for the central portion of the poc
gene appended in the correct reading frame (Fig. 1). The gene
product would contain 36,200 Da of the trpE polypeptide
joined to 87,700 Da of poi protein; translational termination
of the fusion protein would occur at an amber codon in the
vector immediately downstream of the po sequences.
In an attempt to form smaller protein products that would
more closely resemble the authentic enzyme, we modified the
initial construct. We removed the bulk of the trpE sequences
and portions of the 5' end of the poi gene by creating a series of
deletions in the pSH1 plasmid (Fig. 1). pSH1 DNA was cleaved
near the 5' end of the trpE gene with Nru I, and treated with the
exonuclease BAL 31; the DNA was recleaved with Sac I at the
3' end of the trpE gene, and the termini were blunt ended with
nuclease S1. The linear DNA was purified, recyclized with T4
DNA ligase, and used to transform HB101 cells to ampicillin
resistance. Analysis of the DNA from several colonies showed
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that various amounts ofthe trpE and po genes had indeed been
removed (data not shown).
The trpE-pol Fusions Induce Reverse Transcriptase Activity.
Cells containing pATHI1 and pSH1 were starved for
tryptophan, harvested, and lysed, and the crude extracts
were tested for reverse transcriptase activity. The assay
measured the incorporation of radioactive dTTP on poly(rA)
primed with oligo(dT) and was similar to assays previously
used to detect the viral enzyme (15). Extracts prepared from
HB101 cells, or from cells bearing pATH1, showed signifi-
cant basal activity in the assay. The bulk of this background
activity is attributable toDNA polymerase I, which is known
to exhibit reverse transcriptase activity (19). Cells bearing
plasmid pSH1, however, consistently showed 4- to 6-fold
higher activity than the control cells (Fig. 2A; Table 1). The
level of activity per ml in these crude extracts was consid-
erably higher than that in viral harvests taken from infected
NIH/3T3 cell lines. Recovery of the activity in the soluble
fraction required the presence of nonionic detergent and high
salt concentrations (data not shown).
To test whether the increased activity could be attributed
to an increase in the level of DNA polymerase I, the
sensitivity of the activity to the sulfhydryl reagent N-
ethylmaleimide (MalNEt) was determined. The authentic
murine reverse transcriptase is exquisitely sensitive to
MaINEt, while the bacterial DNA polymerase I is resistant
(20). Treatment of the extracts of HB101, or of HB101
carrying pATH1, with MalNEt had no effect on the activity;
but treatment of extracts of cells carrying pSH1 reduced the
high level of activity to that of the control extracts (Table 1).
This result suggested that the pSH1 plasmid induced a
reverse transcriptase activity with properties similar to those
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FIG. 1. Construction of trpE-pol gene fusions.
The central portion of the poi gene was excised from
a cloned copy of the Moloney murine leukemia virus
(M-MuLV) genome by cleavage with Sac I and
HindIll and inserted into the polylinker sequence of
the expression vector pATH1. The resulting plasmid,
pSH1, expressed a 124,000-Da fusion protein and
substantial levels of active reverse transcriptase. In a
second step, the bulk of the trpE sequences and
various amounts of the pol gene were deleted, and
bacterial clones were screened for increased levels of
reverse transcriptase activity. The highest-level pro-
ducer, pSHNB6, encoded an 89,000-Da protein. The
DNA sequence in the region of the deletion, along
with the predicted amino acid sequence of the en-
coded protein, is indicated.
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FIG. 2. Reverse transcriptase assays of bacterial extracts of total
proteins. Aliquots were incubated in a reaction cocktail containing
labeled precursors, and the products were spotted on DEAE paper,
washed, and exposed to x-ray film. The two rows show duplicate
assays. (A) Extracts of HB101 cells carrying the indicated plasmid
were prepared and either 0.1 (lanes 1), 1 ,ul (lanes 2), or 10 ILI (lanes
3) were assayed. Cells carrying pSH1 expressed a 5- to 10-fold higher
level of activity over control cells. (B) Lane C, control cocktail alone.
Lane V, virus preparation from infected NIH/3T3 cells (10 /l). Set
marked Pol A' represents HB101 cells carrying the indicated
plasmids, assayed using 1 Al (lanes 1) or 5 ,4 (lanes 2) of extract. Set
marked Pol A- represents C2110 cells carrying the indicated plas-
mids assayed as described.
Further evidence that the additional activity was not due to
increased levels of DNA polymerase I was obtained by
repeating the assays in a bacterial host carrying a mutation in
polA, the structural gene for the enzyme. Strain C2110
(polAl -) was transformed to ampicillin resistance with
pATH1 and pSH1; because the polA gene is required for
plasmid replication, these transformations occur at low
frequency. The plasmids are apparently maintained by re-
combination with the host chromosome (data not shown).
The continued presence of the polAl - mutation was con-
firmed (21) by testing the strains for sensitivity to methyl
methanesulfonate. Extracts of strain C2110, or of strain
C2110 bearing the pATH1 vector, showed no measurable
reverse transcriptase activity, confirming that the back-
ground aptivity of HB101 was indeed due to DNA polymer-
ase I (Fig. 2B). Extracts of C2110 bearing pSH1 showed the
same high levels of activity seen in the HB101 host (Fig. 2B;
Table 1). It is noteworthy that the single copy of the gene
fusion in the C2110 cells expressed as much activity as the
multicopy genes in HB101.
Removal of the trpE Sequences Results in Increased Enzyme
Activity. Cultures containing each of the variant plasmids
generated by mutagenesis of pSH1 were grown and starved
for tryptophan, and extracts were assayed for reverse
transcriptase activity. Approximately 100 independent
clones were screened, and 2 were found to produce dramati-
cally higher levels of activity than the parental pSH1 plasmid
(Fig. 3). One of these clones, carrying plasmid pSHNB6, was
chosen for further study. Quantitative assays reproducibly
showed that cells carrying the new plasmid expressed a 4- to
8-fold higher level of activity than cells carrying pSH1; the
cells showed as much as a 35-fold increase in activity over
cells carrying the pATH1 vector alone (Table 1).
Sequence analysis of the pSHNB6 DNA (Fig. 1) showed
that 18 codons of trpE were joined, in the correct reading
frame, to the pol gene; the remaining portion of the poi gene
Table 1. DNA synthesis on synthetic templates by bacterial
extracts: Sensitivity of MaINEt
[32P]dTTP
incorporated,
Cells Plasmid Treatment pmol//U4
Exp. 1
HB101 pATH1 Lysate 2.00
+ MalNEt, then DTT 1.55
+ DTT, then MalNEt 1.40
pSH1 Lysate 23.7
+ MalNEt, then DTT 2.48
+ D1T, then MalNEt 15.9
+ premixed DTT/Ma1NEt 16.9
Exp. 2
HB101 pATH1 Lysate 59.6
+ MaINEt, then DTT 45.7
pSH1 Lysate 751
+ MalNEt, then DTT 98.2
pSHNB6 Lysate 2090
+ MalNEt, then DTT 237
C2110 pSH1 Lysate 1590
+ MalNEt, then DTT 164
Exp. 3
HB101 pSH1 DEAE eluate 112
+ MalNEt, then DTT 27.3
40-70% AS fraction 140
+ MalNEt, then DTT 94.4
0-40% AS fraction 252.6
+ MalNEt, then DTT 25.5
Lysates were prepared from the indicated bacterial cells carrying
the indicated plasmids and were assayed for reverse transcriptase
after various treatments. Results expressed as pmol of [32P]dTTP
incorporated into DNA per ttl of extract under standard conditions
(see Methods). Extracts for Exp. 1 were made by the dilute lysis
procedure, those for Exp. 2 were made by the concentrated lysis
procedure, and those for Exp. 3 were made as described in the text.
Protein concentrations (in mg/ml) were as follows: Exp. 1, 1.34 and
1.51; Exp. 2, 3.82, 3.10, 3.53, and 3.6; Exp. 3, 1.05, 2.39, and 0.59.
DTT, dithiothreitol; AS, ammonium sulfate.
contained 7 codons 5' to the start of the mature reverse
transcriptase. The plasmid in the second highly active clone,
pSHNB63, also retained similar trpE coding sequences (data
not shown). These results suggest that the presence of the
trpE codons upstream of this site may help to stabilize the
protein product.
Analysis of Fusion Proteins Encoded by pSH1 and pSHNB6.
We next analyzed the polypeptides synthesized in HB101
cells carrying the pSH1 andpSHNB6 plasmids. Both the total
proteins and the proteins remaining insoluble after addition of
detergent and high salt concentrations were isolated (17).
These fractions were subjected to NaDodSO4/polyacrylam-
ide gel electrophoresis, and the proteins were detected by
Coomassie stain (Fig. 4A). The sequence ofthe pSHl plasmid
predicted the formation of a fusion protein containing both
the trpE and pol polypeptides, of 124,000 Da; cells carrying
pSH1 exhibited a major new protein migrating at %120,000
Da, in good agreement with the expected size. Virtually all of
this polypeptide was recovered in the insoluble fraction. In
addition, many smaller proteins specific to cells carrying
pSH1 were detected. These proteins, ranging in size from
110,000 to 52,000 Da, represented a major portion of the total
mass of the new protein induced by pSH1. We have found
that extended incubation ofthe extracts to allow autolysis did
not increase the formation of these smaller proteins and that
the addition of. protease inhibitors during the lysis did not
reduce the formation of these products.
The structure of pSHNB6 plasmid predicted the synthesis
of a protein of 89,000 Da; examination of cells carrying
4946 Biochemistry: Tanese et aL




































FIG. 3. Reverse transcriptase assays as a screen of cloned
variants of the pSH1 plasmid. Indicated amounts of total protein
extract from each clone were assayed as described in Fig. 2. Samples
C and V are cocktail alone and viral preparations. Cells carrying
pATH1 and pSH1 are shown as standards.
pSHNB6 showed substantial amounts of a new protein of
-90,000 Da, as well as lesser amounts of smaller proteins
(Fig. 4B). These proteins could be detected in total lysates,
but there were high levels of other bacterial proteins in the
same region of the gels. Analysis of the proteins labeled with
[35S]methionine at the time of induction of the trpE gene
clearly revealed the 90,000-Da protein and two major species
at -70,000 and -60,000 Da.
The identity ofthese proteins as products ofthe gene fusion
was confirmed by immunoprecipitation with specific anti-
sera. Cells were labeled with [35S]methionine after induction
of the trp operon. The proteins were extracted with deter-
gents, immunoprecipitated, and analyzed by electrophoresis
and fluorography (Fig. 4C). Cells carrying pSH1 contained
new proteins reactive with the specific sera. A protein of
120,000 Da and a number of smaller polypeptides ranging in
size from 110,000 to 60,000 Da were barely detectable with
the trpE serum (lane 6). A similar spectrum of proteins was
readily seen with either of two sera reactive with reverse
transcriptase (lanes 7 and 8), demonstrating that the new
proteins contain determinants of both trpE and reverse
transcriptase. The soluble fractions were highly enriched for
the smaller proteins relative to the full-length product,
compared with the insoluble fraction, suggesting that the
small proteins were selectively extracted.
Immunoprecipitation of the proteins from cells carrying
pSHNB6 with sera specific for viral reverse transcriptase
showed that a 90,000-Da protein and at least one major
smaller protein were also recognized by the sera (Fig. 4C,
lanes 11 and 12). A higher proportion ofthe full-size pSHNB6
protein was recovered in the soluble fraction than with the
corresponding pSH1 protein. Thus, the removal of the bulk
of the trpE sequences, and possibly part of the 5' pol
sequences, resulted in the synthesis of a smaller protein with
increased solubility, improved stability to proteolytic degra-
dation, and exhibiting a higher level of reverse transcriptase
activity. We have not determined whether the higher activity
is due solely to an increase in the amount of soluble full-size
protein recovered, or whether it is also due to an increase in
the specific activity of the enzyme.
Partial Purification of the Fusion Proteins. To characterize
further the new activities induced by the gene fusions, and to
demonstrate that the new DNA synthetic activity was not due
to DNA polymerase I, we partially purified the activities. The
bulk of the DNA in the solution was removed by precipitation
with streptomycin sulfate; 80% of the activity remained soluble
through this procedure. The material was applied to a DEAE
cellulose column at a low ionic strength, and the activity was
recovered by elution with buffer containing 0.2 M NaCl.
Fractionation of the eluate from cells carrying pSH1 by
ammonium sulfate precipitation showed (Table 1) that most
of the activity was recovered in the fraction precipitated by
40% saturated ammonium sulfate. The bulk (90%) of the
activity in this fraction was sensitive to MaINEt, indicating
that the activity was due to pSH1 enzyme. The rest of the
initial activity was recovered in the 40-70% ammonium
sulfate fraction, known to contain DNA polymerase I (22).
This activity, as expected, was largely resistant to MalNEt
treatment.
The activity induced by pSHNB6 behaved similarly. After
elution from DEAE cellulose, the bulk of this activity was
precipitated by addition of ammonium sulfate to 45% of
saturation. The crude material was 23% resistant to MalNEt.
Greater than 90% of the activity that was precipitated by
ammonium sulfate was sensitive and was, therefore, enriched
for reverse transcriptase-like activity; the activity that re-
mained soluble was now 72% resistant and, therefore, con-
sisted largely of DNA polymerase I. Further purification of
the pSHNB6 protein on phosphocellulose showed that the
activity could be bound and eluted with buffer containing
0.1-0.2 M NaCl. Preliminary characterization of this activity
showed that long DNA products could be synthesized, and
that RNase H activity had copurified through these steps. A
more detailed description of the purification and characteri-
zation of this and similar fusion proteins will be published
elsewhere (23).
DISCUSSION
These experiments demonstrate that portions of the pol gene
of a mammalian retrovirus can be expressed as a gene fusion
with the bacterial trpE gene. The fusion proteins are suf-
ficiently abundant and stable to be detected after electropho-
resis of the total bacterial proteins and are major proteins in
an insoluble fraction of the lysate. Our crude estimate is that
the pol-related products represent ;1% of the total protein
after induction of the trp operon. Extracts containing these
proteins show reverse transcriptase activity, as assayed by
B c
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FIG. 4. NaDodSO4/polyacrylamide gel electrophoresis of bacterial proteins from HB101 cells carrying various plasmids. (A) Proteins
analyzed by Coomassie blue staining. Lanes: 1, total proteins of cells containing vector pATH1; 2, total proteins of cells containing plasmid
pSH1; 3, insoluble fraction from cells carrying pATH1; 4, insoluble fraction from cells carrying pSH1. The major new proteins are indicated
by the arrowheads. Positions of the molecular size standards in kDa are indicated. (B) Lanes: 1 and 2, Coomassie stain of insoluble proteins;
1, cells without plasmid; 2, cells carrying pSHNB6; 3, fluorogram of proteins labeled after induction of the trp operon in cells carrying pSHNB6.
Molecular size standards (in kDa) are indicated. Major bands induced by pSHNB6 are visible at 90, 70, and 60 kDa. (C) Immunoprecipitation
of bacterial proteins. Lanes: 1-4, proteins of control cells carrying the vector pATH1; 5-8, proteins of cells carrying pSH1; 9-12, proteins of
cells carrying pSHNB6. Lanes 1, 5, and 9, normal rabbit serum. Lanes 2, 6, and 10, rabbit serum specific for the TrpE protein. Lanes 3, 7, and
11, NCI serum 775-424 specific for reverse transcriptase. Lanes 4, 8, and 12, NCI serum 775-454 specific for reverse transcriptase. Molecular
size standards (in kDa) are indicated.
the synthesis of DNA on ribohomopolymer templates. The
level of activity is many fold greater than the low activity due
to the endogenous DNA polymerase I, is independent of the
polA gene in the host, and shows biochemical properties
distinct from those of this enzyme.
It is clear that the gene constructs lead to the formation of
shorter protein products as well, probably formed by degra-
dation of the primary translation product within the cell. The
shorter products may be responsible for much of the detect-
able activity. Thus, modifications in the gene fusion that
allow the direct formation of similar smaller proteins might
yield higher levels of recoverable activity. The increased
activity seen for the pSHNB6 construct is consistent with this
notion. Recently, further efforts to trim the size of the gene
to its minimum have led to the synthesis of products with
increased solubility, stability, and activity (23).
We believe that the expression of the murine reverse
transcriptase in bacterial cells will lead to several important
projects. Firstly, the availability of large quantities of the
purified enzyme will allow extensive characterization of the
enzyme. Secondly, mutations can be readily introduced into
the cloned gene fusions, and large numbers of bacterial
cultures can be screened for the presence of rare variants
exhibiting desirable changes in the activity. It may be
possible, for example, to construct variants that do not
express RNase H activity. Thirdly, mutations such as
temperature-sensitive mutations can also be generated, and a
DNA fragment containing the alteration can be recovered and
reinserted into the complete viral genome. In this way, it may
be possible to study the effects ofmany new mutations on the
retroviral life cycle and determine new functions for the
reverse transcriptase enzyme.
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